Latest Europe News

ImpediMed has successfully closed an oversubscribed Share Purchase Plan, raising $2.1 million following a $13.2 million institutional placement. The strong shareholder response underscores confidence ahead of a key shareholder vote.

OncoSil Medical has cleared a major regulatory hurdle as its Humanitarian Device Exemption application nears FDA approval, while its TRIPP-FFX trial shows promising results combining OncoSil with standard chemotherapy for pancreatic cancer.

Helloworld Travel has downgraded its FY26 Underlying EBITDA forecast to $57-$62 million, citing the impact of the ongoing Middle East conflict on airline capacity and travel bookings. Despite near-term setbacks, forward bookings from July show signs of recovery.

Boresight Ltd (ASX: BST) is seeking to raise $8 million through a public offer to expand its cost-effective military drone manufacturing, targeting growth in the US and European markets.

Island Pharmaceuticals has kicked off GMP manufacturing of its antiviral Galidesivir to support late-stage Marburg virus studies under the FDA Animal Rule, marking a key step towards regulatory submission and biodefence readiness.

Control Bionics advances its neural-signal technology across assistive communication, sports, and medical sectors, securing key US reimbursement and distribution agreements while broadening its international footprint.

Cynata Therapeutics secures a crucial regulatory green light from the EMA’s Paediatric Committee for its CYP-001 treatment in children with acute graft versus host disease, paving the way for sequential adult and paediatric trials in Europe.

Scales Corporation has declared a final FY2025 dividend of 12.5 cents per share, lifting total dividends for the year to 25 cents, representing 59% of underlying net profit. The company also introduced a Dividend Reinvestment Plan offering shares at a 2% discount.

Collins Foods has expanded its German presence by acquiring eight KFC restaurants in Bavaria, increasing its portfolio by 50% and strengthening its growth strategy in Europe.

Viridis Mining has secured a non-binding Letter of Intent with Solvay to supply Mixed Rare Earth Carbonate from its Colossus Project, aiming for commercial production by 2028 and advancing Western-aligned rare earth supply chains.

Evion Group has appointed former Australian Ambassador to the US, Arthur Sinodinos, as Strategic Advisor to accelerate its US critical minerals strategy following its acquisition of the CARP Fluorspar Project in Nevada.

Corporate Travel Management reports progress on UK customer remediation with funding plans underway and final agreements near completion. The company maintains strong client retention above 97% and aims to release audited FY25 and reviewed 1H26 financials by end of June, eyeing a swift return to ASX trading.